Your browser doesn't support javascript.
loading
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration.
Ryu, Jae Kyu; Rafalski, Victoria A; Meyer-Franke, Anke; Adams, Ryan A; Poda, Suresh B; Rios Coronado, Pamela E; Pedersen, Lars Østergaard; Menon, Veena; Baeten, Kim M; Sikorski, Shoana L; Bedard, Catherine; Hanspers, Kristina; Bardehle, Sophia; Mendiola, Andrew S; Davalos, Dimitrios; Machado, Michael R; Chan, Justin P; Plastira, Ioanna; Petersen, Mark A; Pfaff, Samuel J; Ang, Kenny K; Hallenbeck, Kenneth K; Syme, Catriona; Hakozaki, Hiroyuki; Ellisman, Mark H; Swanson, Raymond A; Zamvil, Scott S; Arkin, Michelle R; Zorn, Stevin H; Pico, Alexander R; Mucke, Lennart; Freedman, Stephen B; Stavenhagen, Jeffrey B; Nelson, Robert B; Akassoglou, Katerina.
Afiliação
  • Ryu JK; Gladstone Institutes, San Francisco, CA, USA.
  • Rafalski VA; Gladstone Institutes, San Francisco, CA, USA.
  • Meyer-Franke A; Gladstone Institutes, San Francisco, CA, USA.
  • Adams RA; Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
  • Poda SB; Lundbeck Research USA, Paramus, NJ, USA.
  • Rios Coronado PE; Gladstone Institutes, San Francisco, CA, USA.
  • Pedersen LØ; H. Lundbeck A/S, Copenhagen, Denmark.
  • Menon V; Lundbeck Research USA, Paramus, NJ, USA.
  • Baeten KM; Gladstone Institutes, San Francisco, CA, USA.
  • Sikorski SL; Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
  • Bedard C; Gladstone Institutes, San Francisco, CA, USA.
  • Hanspers K; Gladstone Institutes, San Francisco, CA, USA.
  • Bardehle S; Gladstone Institutes, San Francisco, CA, USA.
  • Mendiola AS; Gladstone Institutes, San Francisco, CA, USA.
  • Davalos D; Gladstone Institutes, San Francisco, CA, USA.
  • Machado MR; Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Chan JP; Gladstone Institutes, San Francisco, CA, USA.
  • Plastira I; Gladstone Institutes, San Francisco, CA, USA.
  • Petersen MA; Gladstone Institutes, San Francisco, CA, USA.
  • Pfaff SJ; Institute of Molecular Biology and Biochemistry, Medical University Graz, Graz, Austria.
  • Ang KK; Gladstone Institutes, San Francisco, CA, USA.
  • Hallenbeck KK; Division of Neonatology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Syme C; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Hakozaki H; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Ellisman MH; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Swanson RA; Gladstone Institutes, San Francisco, CA, USA.
  • Zamvil SS; National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.
  • Arkin MR; National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.
  • Zorn SH; Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
  • Pico AR; Neurology Service, San Francisco Veteran Affairs Medical Center, San Francisco, CA, USA.
  • Mucke L; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
  • Freedman SB; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
  • Stavenhagen JB; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Nelson RB; Lundbeck Research USA, Paramus, NJ, USA.
  • Akassoglou K; Gladstone Institutes, San Francisco, CA, USA.
Nat Immunol ; 19(11): 1212-1223, 2018 11.
Article em En | MEDLINE | ID: mdl-30323343
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrinogênio / Doenças Neurodegenerativas / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrinogênio / Doenças Neurodegenerativas / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos